Short Duration Perioperative Administration of Ledipasvir/Sofosbuvir Is Safe and Effective in Preventing HCV Recurrence After Liver Transplant. Article

Web of Science: 000383373902374
Industry Collaboration

Cited authors

  • Verna, E.; Levitsky, J.; O'Leary, J.; Bzowej, N.; Moonka, D.; Hyland, R.; Brainard, D.; McHutchison, J.; Terrault, N.

Authors

Publication date

  • 2016

Published in

International Standard Serial Number (ISSN)

  • 1600-6135

Start page

  • 333

End page

  • 334

Volume

  • 16